Prospective study shows clinical improvement in dogs with inflammatory enteropathy and hypoalbuminemia, suggesting MSC therapy is beneficial.
Repeated intravenous infusions of allogeneic adipose-derived MSCs led to a clinical improvement in some dogs with refractory CIE without marked acute adverse events. Our results suggest that MSC therapy is particularly effective for CIE dogs with hypoalbuminemia.
No takes yet. Share an insight, caveat, or question.
Masaki Michishita (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: